Company / Gross Profit per Share
Beta Bionics, Inc. Gross Profit per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$8.33
FY2025
5-year range
$1.19 / $8.33
FY2023-FY2025
Trend
+23.1%
vs FY2024
Sector context
#54 of 99
Health Care
What the data says
At $8.33, Beta Bionics, Inc.'s gross profit per share ranks #54 of 99 in the Health Care sector. Improved from $1.19 to $8.33 over the past 2 years.
Based on SEC 10-K filings.
8.33 in FY2025.
Improved from $1.19 to $8.33 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#54 of 99 in Health CareTop 55% of 99This company $8.33 Sector average $13.99
▼
-40.4% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 23.1% year-over-year.
- Ranks #54 out of 99 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.33 | +23.1% |
| FY2024 | $6.77 | +468.9% |
| FY2023 | $1.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026